[go: up one dir, main page]

GB202308304D0 - A fusion peptide for activation of the apj and/or glp-1 receptors - Google Patents

A fusion peptide for activation of the apj and/or glp-1 receptors

Info

Publication number
GB202308304D0
GB202308304D0 GBGB2308304.1A GB202308304A GB202308304D0 GB 202308304 D0 GB202308304 D0 GB 202308304D0 GB 202308304 A GB202308304 A GB 202308304A GB 202308304 D0 GB202308304 D0 GB 202308304D0
Authority
GB
United Kingdom
Prior art keywords
apj
glp
receptors
activation
fusion peptide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB2308304.1A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ulster University
Original Assignee
Ulster University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ulster University filed Critical Ulster University
Priority to GBGB2308304.1A priority Critical patent/GB202308304D0/en
Publication of GB202308304D0 publication Critical patent/GB202308304D0/en
Priority to PCT/EP2024/064554 priority patent/WO2024246015A1/en
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/605—Glucagons
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/57563—Vasoactive intestinal peptide [VIP]; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Endocrinology (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Vascular Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
GBGB2308304.1A 2023-06-02 2023-06-02 A fusion peptide for activation of the apj and/or glp-1 receptors Ceased GB202308304D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GBGB2308304.1A GB202308304D0 (en) 2023-06-02 2023-06-02 A fusion peptide for activation of the apj and/or glp-1 receptors
PCT/EP2024/064554 WO2024246015A1 (en) 2023-06-02 2024-05-27 A fusion peptide for activation of the apj and / or glp-1 receptors

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB2308304.1A GB202308304D0 (en) 2023-06-02 2023-06-02 A fusion peptide for activation of the apj and/or glp-1 receptors

Publications (1)

Publication Number Publication Date
GB202308304D0 true GB202308304D0 (en) 2023-07-19

Family

ID=87157009

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB2308304.1A Ceased GB202308304D0 (en) 2023-06-02 2023-06-02 A fusion peptide for activation of the apj and/or glp-1 receptors

Country Status (2)

Country Link
GB (1) GB202308304D0 (en)
WO (1) WO2024246015A1 (en)

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6506724B1 (en) 1999-06-01 2003-01-14 Amylin Pharmaceuticals, Inc. Use of exendins and agonists thereof for the treatment of gestational diabetes mellitus
EP1076066A1 (en) 1999-07-12 2001-02-14 Zealand Pharmaceuticals A/S Peptides for lowering blood glucose levels
TW201138808A (en) 2010-05-03 2011-11-16 Bristol Myers Squibb Co Serum albumin binding molecules
JP6359972B2 (en) * 2011-11-03 2018-07-18 ジーランド ファーマ アクティーゼルスカブ GLP-1 receptor agonist peptide gastrin conjugate
TW201518323A (en) 2013-07-25 2015-05-16 Novartis Ag Bioconjugates of synthetic APELIN polypeptides
ES2805743T3 (en) 2015-03-24 2021-02-15 Inst Nat Sante Rech Med Method and pharmaceutical composition for use in the treatment of diabetes
CN117510646A (en) * 2022-08-03 2024-02-06 无锡市华盛康肽生物技术有限公司 Dual-function fusion protein and application thereof

Also Published As

Publication number Publication date
WO2024246015A1 (en) 2024-12-05

Similar Documents

Publication Publication Date Title
IL288479A (en) Glucagon-like peptide 1 receptor agonists
IL289887A (en) Fusion polypeptide for immunotherapy
IL288143A (en) Natriuretic peptide receptor 1 antibodies and methods of use
EP4093875A4 (en) Ligand-binding fusion proteins
IL277865A (en) C-type natriuretic peptide engrafted antibodies
IL290675A (en) Therapeutic fusion proteins
GB202308304D0 (en) A fusion peptide for activation of the apj and/or glp-1 receptors
IL308397A (en) Macrocyclic glucagon-like peptide 1 receptor agonists
EP4148064A4 (en) Polypeptide derivative having dual receptor agonistic action and use thereof
GB2600564B (en) A fusion protein comprising IL13
IL320810A (en) Glucagon-like peptide 1 receptor agonists
DK3498291T5 (en) Pharmaceutical composition and biomaterial comprising a parathyroid hormone (PTH) fusion peptide conjugated with a bone tissue-selective peptide
GB202113559D0 (en) Fusion polypeptide
IL308240A (en) Fusion polypeptides
EP3755327A4 (en) Calcitonin gene-related peptide (cgrp) antagonist antibodies
SG11202107147WA (en) Adhesion promoter for piezoceramic hydrophone
GB201913804D0 (en) Fusion polypeptides
GB202219551D0 (en) Peptide fusion
HK40062412A (en) Natriuretic peptide receptor 1 antibodies and methods of use
HK40104653A (en) Anti-growth hormone antibody
AU2021902667A0 (en) Fusion polypeptide
EP4045097C0 (en) SEALING MATERIAL FOR A MEDICAL IMPLANT
GB202307932D0 (en) Fusion protein
GB202307936D0 (en) Fusion protein
GB2603724B (en) A multi-layered structural and material system assembly

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)